Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
2.770
-0.520 (-15.81%)
At close: Dec 3, 2024, 4:00 PM
2.830
+0.060 (2.17%)
After-hours: Dec 3, 2024, 4:43 PM EST

Relmada Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-86.49-98.79-157.04-125.75-59.46-15.01
Upgrade
Depreciation & Amortization
---000
Upgrade
Loss (Gain) From Sale of Investments
-1.020.244.811.250.02-
Upgrade
Stock-Based Compensation
33.3543.8144.1940.4920.783.17
Upgrade
Other Operating Activities
---6.35---0.39
Upgrade
Change in Accounts Receivable
-0.51-0.51---
Upgrade
Change in Accounts Payable
-0.51-1.760.422.857.820.16
Upgrade
Change in Other Net Operating Assets
1.464.3210.68-10.713.03-0.03
Upgrade
Operating Cash Flow
-53.21-51.66-103.8-91.87-27.81-12.09
Upgrade
Investment in Securities
47.9650.4519.73-54.12-34.45-80.16
Upgrade
Investing Cash Flow
47.9650.4519.73-54.12-34.45-80.16
Upgrade
Short-Term Debt Repaid
-----0.11-
Upgrade
Total Debt Repaid
-----0.11-0.37
Upgrade
Net Debt Issued (Repaid)
-----0.11-0.37
Upgrade
Issuance of Common Stock
0.25-44.7187.9428.58126.48
Upgrade
Other Financing Activities
-0.21-0.10.32---
Upgrade
Financing Cash Flow
0.03-0.145.02187.9428.47126.11
Upgrade
Net Cash Flow
-5.21-1.3-39.0541.95-33.7833.85
Upgrade
Free Cash Flow
-53.21-51.66-103.8-91.87-27.81-12.09
Upgrade
Free Cash Flow Per Share
-1.76-1.72-3.50-5.23-1.78-1.31
Upgrade
Cash Interest Paid
----00.01
Upgrade
Levered Free Cash Flow
-23.01-17.91-52.34-46.02-5.54-
Upgrade
Unlevered Free Cash Flow
-23.01-17.91-52.34-46.02-5.54-
Upgrade
Change in Net Working Capital
-0.91-3.09-4.257.95-10.77-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.